Meredith M. Regan, ScD
Meredith M. Regan, ScD
Dana-Farber Cancer Institute, Harvard Medical School
Verified email at ds.dfci.harvard.edu
Title
Cited by
Cited by
Year
Prognostic factors for overall survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor–targeted agents: results from a large …
DYC Heng, W Xie, MM Regan, MA Warren, AR Golshayan, C Sahi, ...
Journal of clinical oncology 27 (34), 5794-5799, 2009
14622009
Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in Breast Cancer working group
M Dowsett, TO Nielsen, R A’Hern, J Bartlett, RC Coombes, J Cuzick, ...
Journal of the National cancer Institute 103 (22), 1656-1664, 2011
14012011
Effect of sleep loss on C-reactive protein, an inflammatory marker of cardiovascular risk
HK Meier-Ewert, PM Ridker, N Rifai, MM Regan, NJ Price, DF Dinges, ...
Journal of the American College of Cardiology 43 (4), 678-683, 2004
10592004
Randomized phase III trial of high-dose interleukin-2 versus subcutaneous interleukin-2 and interferon in patients with metastatic renal cell carcinoma
DF McDermott, MM Regan, JI Clark, LE Flaherty, GR Weiss, TF Logan, ...
Journal of clinical oncology 23 (1), 133-141, 2004
8852004
Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23–01): a phase 3 randomised controlled trial
V Galimberti, BF Cole, S Zurrida, G Viale, A Luini, P Veronesi, P Baratella, ...
The lancet oncology 14 (4), 297-305, 2013
8792013
Androgen receptor regulates a distinct transcription program in androgen-independent prostate cancer
Q Wang, W Li, Y Zhang, X Yuan, K Xu, J Yu, Z Chen, R Beroukhim, ...
Cell 138 (2), 245-256, 2009
8532009
The 8q24 cancer risk variant rs6983267 shows long-range interaction with MYC in colorectal cancer
MM Pomerantz, N Ahmadiyeh, LI Jia, P Herman, MP Verzi, ...
Nature genetics 41 (8), 882-884, 2009
6722009
Adjuvant exemestane with ovarian suppression in premenopausal breast cancer
O Pagani, MM Regan, BA Walley, GF Fleming, M Colleoni, I Láng, ...
New England Journal of Medicine 371 (2), 107-118, 2014
6432014
Adjuvant ovarian suppression in premenopausal breast cancer
PA Francis, MM Regan, GF Fleming, I Láng, E Ciruelos, M Bellet, ...
New England Journal of Medicine 372 (5), 436-446, 2015
5852015
External validation and comparison with other models of the International Metastatic Renal-Cell Carcinoma Database Consortium prognostic model: a population-based study
DYC Heng, W Xie, MM Regan, LC Harshman, GA Bjarnason, ...
The lancet oncology 14 (2), 141-148, 2013
5632013
De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017
G Curigliano, HJ Burstein, E P Winer, M Gnant, P Dubsky, S Loibl, ...
Annals of Oncology 28 (8), 1700-1712, 2017
5602017
Carbonic anhydrase IX expression predicts outcome of interleukin 2 therapy for renal cancer
M Atkins, M Regan, D McDermott, J Mier, E Stanbridge, A Youmans, ...
Clinical cancer research 11 (10), 3714-3721, 2005
4992005
Prognostic and predictive value of centrally reviewed expression of estrogen and progesterone receptors in a randomized trial comparing letrozole and tamoxifen adjuvant therapy …
G Viale, MM Regan, E Maiorano, MG Mastropasqua, P Dell'Orto, ...
Journal of Clinical Oncology 25 (25), 3846-3852, 2007
4372007
Association of cystic fibrosis with abnormalities in fatty acid metabolism
SD Freedman, PG Blanco, MM Zaman, JC Shea, M Ollero, IK Hopper, ...
New England Journal of Medicine 350 (6), 560-569, 2004
3832004
Melatonin treatment for age-related insomnia
IV Zhdanova, RJ Wurtman, MM Regan, JA Taylor, JP Shi, OU Leclair
The Journal of Clinical Endocrinology & Metabolism 86 (10), 4727-4730, 2001
3662001
Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical …
MM Regan, P Neven, A Giobbie-Hurder, A Goldhirsch, B Ejlertsen, ...
The lancet oncology 12 (12), 1101-1108, 2011
3602011
8q24 prostate, breast, and colon cancer risk loci show tissue-specific long-range interaction with MYC
N Ahmadiyeh, MM Pomerantz, C Grisanzio, P Herman, L Jia, V Almendro, ...
Proceedings of the National academy of sciences 107 (21), 9742-9746, 2010
3482010
Prognostic and predictive value of centrally reviewed Ki-67 labeling index in postmenopausal women with endocrine-responsive breast cancer: results from Breast International …
G Viale, A Giobbie-Hurder, MM Regan, AS Coates, MG Mastropasqua, ...
Journal of clinical oncology 26 (34), 5569, 2008
3382008
CYP2D6 Genotype and Tamoxifen Response in Postmenopausal Women with Endocrine-Responsive Breast Cancer: The Breast International Group 1-98 Trial
MM Regan, B Leyland-Jones, M Bouzyk, O Pagani, W Tang, R Kammler, ...
Journal of the National Cancer Institute 104 (6), 441-451, 2012
3232012
Predictive value of tumor Ki-67 expression in two randomized trials of adjuvant chemoendocrine therapy for node-negative breast cancer
G Viale, the International Breast Cancer Study Group, MM Regan, ...
JNCI: Journal of the National Cancer Institute 100 (3), 207-212, 2008
2742008
The system can't perform the operation now. Try again later.
Articles 1–20